Martek Announces Second Quarter 2009 Financial Results
...compared with $9.2 million, or $0.28 per diluted share, in last year's second quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "The continued execution of our business plan allowed Martek to generate record revenues and profits in the second quarter. These results were a...Missouri Behavioral Pharmacy Management Program Receives 2008 SAMHSA Science and Service Award
...08 Science and Service Award Winners, October 22, 2008 News Release. http://www.samhsa.gov/newsroom/advisories/0810222125.aspx . (2) Ning A, dubin WR, Parks JJ. Pharmacy costs: Finding a role for quality. Psychiatric Services, 2005; 56:909-11. ...Martek Announces First Quarter 2008 Financial Results
... 2008 compared with $2.8 million, or $0.08 per diluted share, in last year's first quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "The results for the first quarter show a solid start to fiscal 2008 and reflect our continued execution of our business plan. During the first ...Martek Announces Third Quarter 2007 Financial Results
...share, compared with $4.6 million, or $0.14 per diluted share, in last year's third quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "Martek's improved financial performance this quarter resulted from growth in both sales of DHA for uses other than infant formula and sales of ...Martek Announces First Quarter 2009 Financial Results
...09 compared with $8.7 million, or $0.26 per diluted share, in last year's first quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "Despite the troubling economy, Martek's first quarter results showed both revenue and bottom line growth reflecting the strength of our core in...Martek Announces Fourth Quarter and FY 2008 Financial Results
... a 17% increase. (see "Reconciliation of GAAP to Non-GAAP Net Income Measure" below). Commenting on the quarter, Chief Executive Officer Steve dubin said, "Our results in this year's fourth quarter as well as the full fiscal year 2008 reflect the continued execution of our business plan. During the...Martek Announces Third Quarter 2008 Financial Results
...p 47% compared with $6.1 million, or $0.19 per diluted share, in last year's third quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "Martek's third quarter was another solid quarter for the Company reflecting revenues and earnings in excess of our projections as well as the c...Daniel B. Dubin, M.D., Joins NanoBio Corp.'s Board of Directors
...l B. Dubin, M.D., to its board of directors. Dr. dubin currently serves as Vice Chairman and a Director a...nfections." A Harvard-trained dermatologist, Dr. dubin served as Ambulatory Medical Director of the derma...tice at Brigham and Women's Hospital. In 1996, Dr. dubin co-founded MEDACorp to provide life science compan...Martek Announces Second Quarter 2008 Financial Results
...2008 compared with $4.9 million, or $0.15 per diluted share, in last year's second quarter. Commenting on the quarter, Chief Executive Officer Steve dubin said, "Martek's strong second quarter results reflect the continued execution of the Company's business plan. Martek's core infant formula business gr...Martek Announces Fourth Quarter and FY 2007 Financial Results
...and 2006, respectively (see "Reconciliation of GAAP to Non-GAAP Net Income Measure" below). Commenting on the quarter, Chief Executive Officer Steve dubin said, "Our results in this year's fourth quarter confirm that our strategies are on target and demonstrate the progress we have made against our key f...